|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.76 USD | +4.11% |
|
-12.44% | +60.23% |
| Market Cap | 4.28B 3.74B 3.45B 3.18B 5.99B 412B 6.13B 41.23B 16.22B 202B 16.07B 15.71B 695B | P/E 2026 * |
-20.7x | P/E 2027 * | -24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.58B 2.26B 2.08B 1.92B 3.62B 249B 3.7B 24.87B 9.78B 122B 9.69B 9.48B 419B | EV / Sales 2026 * |
12.3x | EV / Sales 2027 * | 55.5x |
| Free-Float |
99.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edgewise Therapeutics, Inc.
| 1 day | +4.11% | ||
| 1 week | -12.44% | ||
| Current month | -2.14% | ||
| 1 month | +8.01% | ||
| 3 months | +15.48% | ||
| 6 months | +45.16% | ||
| Current year | +60.23% |
| 1 week | 37.25 |  | 44.54 |
| 1 month | 35.96 | | 48.4 |
| Current year | 22.78 | | 48.4 |
| 1 year | 12.3 | | 48.4 |
| 3 years | 5.12 | | 48.4 |
| 5 years | 5.12 | | 48.4 |
| 10 years | 5.12 | | 48.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Russell
CTO | Chief Tech/Sci/R&D Officer | 56 | 2017-05-31 |
Kevin Koch
CEO | Chief Executive Officer | 65 | 2017-07-31 |
Michael Nofi
DFI | Director of Finance/CFO | 55 | 2025-11-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Koch
BRD | Director/Board Member | 65 | 2017-05-31 |
Peter Thompson
CHM | Chairman | 66 | 2017-07-31 |
Alan Russell
BRD | Director/Board Member | 56 | 2017-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Fiscal year | Founder | 600,000 | 0.5577% | ||
| 7/1/26 | Free | Director | 319 | 0.0003% | ||
| 6/5/26 | Free | Director | 16,377 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.11% | -12.44% | +193.65% | +457.64% | 4.28B | |
| +0.24% | -1.54% | +52.85% | +71.85% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.32% | 52.1B | |
| +0.80% | -6.31% | +5.62% | +417.78% | 23.48B | |
| -0.09% | -0.01% | -16.85% | -15.41% | 23.13B | |
| -5.95% | -2.58% | +29.53% | -9.47% | 19.36B | |
| -1.14% | +0.03% | +31.67% | -30.65% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +314.96% | 15.2B | |
| -6.91% | -5.83% | +25.17% | +644.30% | 14.83B | |
| +0.43% | -1.03% | +25.75% | +189.74% | 14.06B | |
| Average | -2.08% | -3.61% | +55.85% | +211.41% | 23.78B | |
| Weighted average by Cap. | -2.68% | -2.54% | +42.32% | +148.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 209M 183M 169M 156M 293M 20.16B 300M 2.02B 794M 9.88B 786M 769M 33.99B | 46.67M 40.78M 37.63M 34.69M 65.38M 4.49B 66.83M 450M 177M 2.2B 175M 171M 7.58B |
| Net income | -207M -180M -167M -154M -289M -19.89B -296M -1.99B -783M -9.74B -776M -759M -33.54B | -174M -152M -140M -129M -244M -16.78B -249M -1.68B -660M -8.22B -654M -640M -28.28B |
| Net Debt | -1.7B -1.48B -1.37B -1.26B -2.38B -163B -2.43B -16.36B -6.43B -80.05B -6.37B -6.23B -276B | -1.69B -1.48B -1.36B -1.26B -2.37B -163B -2.42B -16.28B -6.4B -79.68B -6.34B -6.21B -274B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$39.76 | +4.11% | 744,698 |
| 26-07-16 | US$38.19 | -6.47% | 691,842 |
| 26-07-15 | US$40.83 | +2.77% | 1,107,014 |
| 26-07-14 | US$39.73 | -3.73% | 1,212,749 |
| 26-07-13 | US$41.27 | -9.12% | 1,037,527 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EWTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
